Nebivolol in chronic heart failure: current evidence and future perspectives.
Lipsic
Erik
E
University Medical Center Groningen, Thoraxcenter, Department of Cardiology, Hanzeplein 1, 9700 RB Groningen, The Netherlands. e.lipsic@thorax.umcg.nl
van Veldhuisen
Dirk J
DJ
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001578:Benzopyrans / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004983:Ethanolamines / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D000068577:Nebivolol; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D004983:Ethanolamines; D000068577:Nebivolol